Open AccessNonalcoholic Fatty Liver Disease and Obesity Treatment
Author(s) -
Katherine T. Brunner,
Cameron J. Henneberg,
Robert M. Wilechansky,
Michelle T. Long
Publication year - 2019
Publication title -
current obesity reports
Language(s) - English
Resource type - Journals
ISSN - 2162-4968
DOI - 10.1007/s13679-019-00345-1
Subject(s) - nonalcoholic fatty liver disease , medicine , pioglitazone , insulin resistance , weight loss , fibrosis , type 2 diabetes , liver biopsy , fatty liver , gastroenterology , diabetes mellitus , obesity , endocrinology , biopsy , disease
Nonalcoholic fatty liver disease (NAFLD), the most prevalent cause of chronic liver disease worldwide, is strongly associated with obesity and insulin resistance.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom